1. Home
  2. CNTB vs HSPO Comparison

CNTB vs HSPO Comparison

Compare CNTB & HSPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • HSPO
  • Stock Information
  • Founded
  • CNTB 2012
  • HSPO 2014
  • Country
  • CNTB United States
  • HSPO United States
  • Employees
  • CNTB N/A
  • HSPO N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • HSPO Blank Checks
  • Sector
  • CNTB Health Care
  • HSPO Finance
  • Exchange
  • CNTB Nasdaq
  • HSPO Nasdaq
  • Market Cap
  • CNTB 68.5M
  • HSPO 87.7M
  • IPO Year
  • CNTB 2021
  • HSPO 2022
  • Fundamental
  • Price
  • CNTB $1.17
  • HSPO $11.25
  • Analyst Decision
  • CNTB Strong Buy
  • HSPO
  • Analyst Count
  • CNTB 1
  • HSPO 0
  • Target Price
  • CNTB $8.00
  • HSPO N/A
  • AVG Volume (30 Days)
  • CNTB 24.6K
  • HSPO 27.4K
  • Earning Date
  • CNTB 09-05-2024
  • HSPO 01-01-0001
  • Dividend Yield
  • CNTB N/A
  • HSPO N/A
  • EPS Growth
  • CNTB N/A
  • HSPO N/A
  • EPS
  • CNTB N/A
  • HSPO 0.33
  • Revenue
  • CNTB $24,116,000.00
  • HSPO N/A
  • Revenue This Year
  • CNTB N/A
  • HSPO N/A
  • Revenue Next Year
  • CNTB $63.90
  • HSPO N/A
  • P/E Ratio
  • CNTB N/A
  • HSPO $34.26
  • Revenue Growth
  • CNTB N/A
  • HSPO N/A
  • 52 Week Low
  • CNTB $0.68
  • HSPO $10.60
  • 52 Week High
  • CNTB $2.84
  • HSPO $11.25
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 44.02
  • HSPO 69.42
  • Support Level
  • CNTB $1.18
  • HSPO $11.17
  • Resistance Level
  • CNTB $1.26
  • HSPO $11.25
  • Average True Range (ATR)
  • CNTB 0.07
  • HSPO 0.00
  • MACD
  • CNTB -0.01
  • HSPO 0.00
  • Stochastic Oscillator
  • CNTB 13.59
  • HSPO 100.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About HSPO Horizon Space Acquisition I Corp.

Horizon Space Acquisition I Corp is a blank check company.

Share on Social Networks: